As liver tumours receive some of their blood supply from the portal vein, we wanted to illustrate the influence of portal blood flow in combination with dearterialization in the treatment of liver tumours. Forty male, inbred Wistar/Furth rats with an adenocarcinoma transplanted to the liver were treated with various inflow occlusions repeated daily for 5 days. Deviation of the portal blood flow alone with an end-side porto-caval shunt did not alter the tumour growth (p 0.089).
INTRODUCTION
The theory that established liver tumours are predominantly supplied from the hepatic artery 1-' has led to extensive use of hepatic artery ligation (HAL), dearterialization and cytotoxic perfusion through the hepatic artery in the treatment of both primary and second- 8 suggesting that portal blood flow to the tumour might play a role during ischemic treatment of liver tumours.
This experiment was designed to find out whether occlusion of both portal and hepatic arterial blood flow was more efficient in retarding the growth of a liver, tumour than either alone and also to study the injurious effects ofsuch procedures on the normal liver. A porto-caval shunt was used to deprive the tumour of its portal supply and the hepatic artery was intermittently and briefly occluded with an implantable occluder as described previously9. Figure 2A -2B ASAT (2A) and ALAT (2B) at different time periods after reperfusion (mean _+ SEM). ASAT and ALAT were released immediately (p < 0.05) after reperfusion and showed a tendency to recover in porto-caval shunt rats dearterialized for 30 min. They had returned to normal 24 hours after reperfusion (p > 0.05). Whereas, the maximum release of ASAT and ALAT in rats with an end-side porto-caval shunt subjected to 60 min of dearterialization was at 2 hours and they did not restore to normal even 24 hours after reperfusion (p < 0.05). 
MATERIALS AND METHODS

